{"id":3411,"date":"2020-04-17T11:53:43","date_gmt":"2020-04-17T10:53:43","guid":{"rendered":"https:\/\/ceptonstrategies.com\/en\/?p=3411"},"modified":"2020-04-17T11:53:43","modified_gmt":"2020-04-17T10:53:43","slug":"covidnews-cepton-inato-3","status":"publish","type":"post","link":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/","title":{"rendered":"COVIDNews CEPTON-INATO #3"},"content":{"rendered":"

The number of interventional trials is still rising, with now 30 trials that will include more than 1,000 patients each. The most tested drugs remain Hydoxychloroquine and antivirals.
\nWe also provide insights on the modes of action of the different drugs tested, thanks to a James M. Sanders et al.<\/a>
\n\"\" \"\"<\/p>\n

<\/p>","protected":false},"excerpt":{"rendered":"

The number of interventional trials is still rising, with now 30 trials that will include more than 1,000 patients each. The most tested drugs remain Hydoxychloroquine and antivirals. We also provide insights on the modes of action of the different drugs tested, thanks to a James M. Sanders et al.<\/p>\n","protected":false},"author":4,"featured_media":3363,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[85],"tags":[],"yoast_head":"\nCOVIDNews CEPTON-INATO #3 – Consulting Firm in Pharmaceutical, MedTech & Healthcare<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVIDNews CEPTON-INATO #3 – Consulting Firm in Pharmaceutical, MedTech & Healthcare\" \/>\n<meta property=\"og:description\" content=\"The number of interventional trials is still rising, with now 30 trials that will include more than 1,000 patients each. The most tested drugs remain Hydoxychloroquine and antivirals. We also provide insights on the modes of action of the different drugs tested, thanks to a James M. Sanders et al.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Consulting Firm in Pharmaceutical, MedTech & Healthcare\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-17T10:53:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"3500\" \/>\n\t<meta property=\"og:image:height\" content=\"2333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marc-Olivier B\u00e9vierre\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marc-Olivier B\u00e9vierre\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/\"},\"author\":{\"name\":\"Marc-Olivier B\u00e9vierre\",\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/person\/188c09921fb1de3e844a50cc08540bf3\"},\"headline\":\"COVIDNews CEPTON-INATO #3\",\"datePublished\":\"2020-04-17T10:53:43+00:00\",\"dateModified\":\"2020-04-17T10:53:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/\"},\"wordCount\":50,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ceptonstrategies.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg\",\"articleSection\":[\"2020\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/\",\"url\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/\",\"name\":\"COVIDNews CEPTON-INATO #3 – Consulting Firm in Pharmaceutical, MedTech & Healthcare\",\"isPartOf\":{\"@id\":\"https:\/\/ceptonstrategies.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg\",\"datePublished\":\"2020-04-17T10:53:43+00:00\",\"dateModified\":\"2020-04-17T10:53:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#primaryimage\",\"url\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg\",\"contentUrl\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg\",\"width\":3500,\"height\":2333},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ceptonstrategies.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COVIDNews CEPTON-INATO #3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ceptonstrategies.com\/#website\",\"url\":\"https:\/\/ceptonstrategies.com\/\",\"name\":\"Cepton Stategies Conseil\",\"description\":\"CEPTON is a parisian consulting firm. Our senior consultants are specialized in the pharmaceutical, medtech and healthcare industries\",\"publisher\":{\"@id\":\"https:\/\/ceptonstrategies.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ceptonstrategies.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ceptonstrategies.com\/#organization\",\"name\":\"Cepton Strategies\",\"url\":\"https:\/\/ceptonstrategies.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2019\/01\/LOGO_CEPTON_CMJN.jpg\",\"contentUrl\":\"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2019\/01\/LOGO_CEPTON_CMJN.jpg\",\"width\":938,\"height\":423,\"caption\":\"Cepton Strategies\"},\"image\":{\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/strategies-cepton\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/person\/188c09921fb1de3e844a50cc08540bf3\",\"name\":\"Marc-Olivier B\u00e9vierre\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ceptonstrategies.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/22d508705e6bb61bcefa8f142de4144b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/22d508705e6bb61bcefa8f142de4144b?s=96&d=mm&r=g\",\"caption\":\"Marc-Olivier B\u00e9vierre\"},\"url\":\"https:\/\/ceptonstrategies.com\/en\/author\/marc-olivier\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COVIDNews CEPTON-INATO #3 – Consulting Firm in Pharmaceutical, MedTech & Healthcare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/","og_locale":"en_US","og_type":"article","og_title":"COVIDNews CEPTON-INATO #3 – Consulting Firm in Pharmaceutical, MedTech & Healthcare","og_description":"The number of interventional trials is still rising, with now 30 trials that will include more than 1,000 patients each. The most tested drugs remain Hydoxychloroquine and antivirals. We also provide insights on the modes of action of the different drugs tested, thanks to a James M. Sanders et al.","og_url":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/","og_site_name":"Consulting Firm in Pharmaceutical, MedTech & Healthcare","article_published_time":"2020-04-17T10:53:43+00:00","og_image":[{"width":3500,"height":2333,"url":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg","type":"image\/jpeg"}],"author":"Marc-Olivier B\u00e9vierre","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marc-Olivier B\u00e9vierre"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#article","isPartOf":{"@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/"},"author":{"name":"Marc-Olivier B\u00e9vierre","@id":"https:\/\/ceptonstrategies.com\/#\/schema\/person\/188c09921fb1de3e844a50cc08540bf3"},"headline":"COVIDNews CEPTON-INATO #3","datePublished":"2020-04-17T10:53:43+00:00","dateModified":"2020-04-17T10:53:43+00:00","mainEntityOfPage":{"@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/"},"wordCount":50,"commentCount":0,"publisher":{"@id":"https:\/\/ceptonstrategies.com\/#organization"},"image":{"@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#primaryimage"},"thumbnailUrl":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg","articleSection":["2020"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/","url":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/","name":"COVIDNews CEPTON-INATO #3 – Consulting Firm in Pharmaceutical, MedTech & Healthcare","isPartOf":{"@id":"https:\/\/ceptonstrategies.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#primaryimage"},"image":{"@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#primaryimage"},"thumbnailUrl":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg","datePublished":"2020-04-17T10:53:43+00:00","dateModified":"2020-04-17T10:53:43+00:00","breadcrumb":{"@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#primaryimage","url":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg","contentUrl":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2020\/04\/markus-spiske-3_SvgDspSTE-unsplash.jpg","width":3500,"height":2333},{"@type":"BreadcrumbList","@id":"https:\/\/ceptonstrategies.com\/en\/covidnews-cepton-inato-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ceptonstrategies.com\/en\/"},{"@type":"ListItem","position":2,"name":"COVIDNews CEPTON-INATO #3"}]},{"@type":"WebSite","@id":"https:\/\/ceptonstrategies.com\/#website","url":"https:\/\/ceptonstrategies.com\/","name":"Cepton Stategies Conseil","description":"CEPTON is a parisian consulting firm. Our senior consultants are specialized in the pharmaceutical, medtech and healthcare industries","publisher":{"@id":"https:\/\/ceptonstrategies.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ceptonstrategies.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ceptonstrategies.com\/#organization","name":"Cepton Strategies","url":"https:\/\/ceptonstrategies.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ceptonstrategies.com\/#\/schema\/logo\/image\/","url":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2019\/01\/LOGO_CEPTON_CMJN.jpg","contentUrl":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2019\/01\/LOGO_CEPTON_CMJN.jpg","width":938,"height":423,"caption":"Cepton Strategies"},"image":{"@id":"https:\/\/ceptonstrategies.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/strategies-cepton"]},{"@type":"Person","@id":"https:\/\/ceptonstrategies.com\/#\/schema\/person\/188c09921fb1de3e844a50cc08540bf3","name":"Marc-Olivier B\u00e9vierre","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ceptonstrategies.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/22d508705e6bb61bcefa8f142de4144b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/22d508705e6bb61bcefa8f142de4144b?s=96&d=mm&r=g","caption":"Marc-Olivier B\u00e9vierre"},"url":"https:\/\/ceptonstrategies.com\/en\/author\/marc-olivier\/"}]}},"_links":{"self":[{"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/posts\/3411"}],"collection":[{"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/comments?post=3411"}],"version-history":[{"count":2,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/posts\/3411\/revisions"}],"predecessor-version":[{"id":3418,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/posts\/3411\/revisions\/3418"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/media\/3363"}],"wp:attachment":[{"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/media?parent=3411"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/categories?post=3411"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ceptonstrategies.com\/en\/wp-json\/wp\/v2\/tags?post=3411"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}